Co-targeting BCL-X <sub>L</sub> and MCL-1 with DT2216 and AZD8055 synergistically inhibits small-cell lung cancer growth without causing on-target toxicities in mice
Sajid Khan(The University of Texas at San Antonio Health Science Center), Daohong Zhou(The University of Texas at San Antonio Health Science Center)
Cited by 0
Related Papers
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity,
|Nature Communications|2021|145
DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas
|Journal of Hematology & Oncology|2020|129